From: Long-term virological outcome in children receiving first-line antiretroviral therapy
Characteristics of children | Values |
---|---|
Number of boys (%) | 200 (51) |
Mean age in years (SD) | 7.6 (3.1) |
Median WAZ score (IQR) | − 2.21 (− 2.7, − 1.5) |
Median HAZ score (IQR) | − 2.1 (− 2.8, − 1.3) |
Median WHZ score (IQR) | − 1.2 (− 1.9, − 0.5) |
Median CD4 cell count (cells/mm3) (IQR) | 388 (269–653) |
Median HIV RNA viral load (copies/ml) (IQR) | 141,000 (25,876–436,000) |
Mean CD4% (SD) | 16.55 (8.82) |
WHO clinical stage | |
 1 | 42 |
 2 | 98 |
 3 | 150 |
 4 | 65 |
CD4 cell count (cells/mm3) | n (%) |
 < 200 | 63 (16%) |
 200–349 | 102 (26%) |
 350–499 | 79 (20%) |
 > 500 | 147 (37%) |
Viral load (copies/ml) | n (%) |
 < 400 | 10 (3%) |
 400–999 | 18 (5%) |
 > 1000 | 361 (92%) |
Number of children on | |
 Efavirenz-based ART regimen | 96 (24%) |
 Nevirapine-based ART regimen | 289 (74%) |
 Other regimens (3NRTIs) | 8 (2%) |